CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,278 enrolled
Drug / intervention
Health Advocates Program +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02746393
NCT02746393N/ACompleted

San Francisco General Hospital (SFGH) Health Advocates Phase II Study

University of California, San Francisco·interventional·Posted Apr 21, 2016·Updated Oct 6, 2020

In Brief

A clinical study evaluating Health Advocates Program and 211 Information Sheet for Conditions Influencing Health Status and Social Determinants of Health. Completed, enrolled 1,278 participants across 1 site.

Detailed Summary

The San Francisco General Hospital (SFGH) Health Advocate Staff II Study is a Randomized Controlled Trial (RCT) that collects survey data and non-invasive biological data from caregivers and children visiting a pediatric urgent care center. Families will be randomized according to a pre-determined randomization schedule into one of two social needs-focused interventions (the Health Advocates Program or a 211 Information active comparator arm). All patients in the study will be followed over a six month period to capture information about changes in social needs, health and health care utilization.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 21, 2016
Enrollment StartJul 1, 2016
Primary CompletionMar 1, 2019
Study CompletionJul 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 10.2 years ago

Interventions

Health Advocates Programother

Provided services and support to address identified social needs from health advocate navigators.

211 Information Sheetother

Receive a printed list of community resources to address social needs.